NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









HeliXon

HeliXon

Private
BeijingHealthcare & Life Scienceshttps://www.helixon.com/

Last Round

Series A

Jun 22, 2022

Total Funding Raised

$74.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

HeliXon is a biotechnology company that develops an artificial intelligence platform for scientific computing to enhance the efficiency of medical research and drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

drug discoveryAI drug discoveryprotein engineeringgenerative protein designantibody therapeuticsin silico drug discoverybiologicsbispecific antibodieshigh-throughput screeningstructure predictioncomputational biologypharma R&DAI-native biotechdrug design platformprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HeliXon Comps

Public and private peers based on sector, stage, and business model.

HeliXon comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HeliXon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2022
AngelOct 1, 2021

HeliXon Investors

Notable investors and investment history

HeliXon investors
InvestorRounds
Hillhouse InvestmentSeries A, Angel
Neumann AdvisorsSeries A
Neumann CapitalSeries A
5Y CapitalSeries A
GL VenturesSeries A
Tsinghua CapitalAngel
Xiang He CapitalSeries A, Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 64% MoM.

  • Jun 22, 2022

    $75M round led by 5Y Capital and Morningside.

HeliXon Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HeliXon Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HeliXon's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range11
Year Founded2021
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.